The Translation Regulatory Subunit eIF3f Controls the Kinase-Dependent mTOR Signaling Required for Muscle Differentiation and Hypertrophy in Mouse

The mTORC1 pathway is required for both the terminal muscle differentiation and hypertrophy by controlling the mammalian translational machinery via phosphorylation of S6K1 and 4E-BP1. mTOR and S6K1 are connected by interacting with the eIF3 initiation complex. The regulatory subunit eIF3f plays a major role in muscle hypertrophy and is a key target that accounts for MAFbx function during atrophy. Here we present evidence that in MAFbx-induced atrophy the degradation of eIF3f suppresses S6K1 activation by mTOR, whereas an eIF3f mutant insensitive to MAFbx polyubiquitination maintained persistent phosphorylation of S6K1 and rpS6. During terminal muscle differentiation a conserved TOS motif in eIF3f connects mTOR/raptor complex, which phosphorylates S6K1 and regulates downstream effectors of mTOR and Cap-dependent translation initiation. Thus eIF3f plays a major role for proper activity of mTORC1 to regulate skeletal muscle size.

[1]  Jean-Luc Pons,et al.  @TOME-2: a new pipeline for comparative modeling of protein–ligand complexes , 2009, Nucleic Acids Res..

[2]  J. Lagirand-Cantaloube,et al.  Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo , 2009, PloS one.

[3]  M. Nelson,et al.  Phosphorylation of the eukaryotic initiation factor 3f by cyclin‐dependent kinase 11 during apoptosis , 2009, FEBS letters.

[4]  S. Goff,et al.  Inhibition of HIV-1 replication by eIF3f , 2009, Proceedings of the National Academy of Sciences.

[5]  A. Csibi,et al.  MAFbx/Atrogin-1 Controls the Activity of the Initiation Factor eIF3-f in Skeletal Muscle Atrophy by Targeting Multiple C-terminal Lysines* , 2009, Journal of Biological Chemistry.

[6]  E. Casanova,et al.  Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. , 2008, Cell metabolism.

[7]  A. Csibi,et al.  eIF3-f function in skeletal muscles: To stand at the crossroads of atrophy and hypertrophy , 2008, Cell cycle.

[8]  N. Offner,et al.  The initiation factor eIF3‐f is a major target for Atrogin1/MAFbx function in skeletal muscle atrophy , 2008, The EMBO journal.

[9]  N. LeBrasseur,et al.  Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. , 2008, Cell metabolism.

[10]  Mee-Sup Yoon,et al.  PLD regulates myoblast differentiation through the mTOR-IGF2 pathway , 2008, Journal of Cell Science.

[11]  N. Zanchin,et al.  The crystal structure of the human Mov34 MPN domain reveals a metal-free dimer. , 2007, Journal of molecular biology.

[12]  Manfred J. Sippl,et al.  Thirty years of environmental health research--and growing. , 1996, Nucleic Acids Res..

[13]  J. Blenis,et al.  RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation* , 2007, Journal of Biological Chemistry.

[14]  J. Hershey,et al.  Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells , 2006, Oncogene.

[15]  J. Shabanowitz,et al.  mTOR‐dependent stimulation of the association of eIF4G and eIF3 by insulin , 2006, The EMBO journal.

[16]  G. Marius Clore,et al.  Using Xplor-NIH for NMR molecular structure determination , 2006 .

[17]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[18]  Steven P. Gygi,et al.  mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events , 2005, Cell.

[19]  D. Glass,et al.  Skeletal muscle hypertrophy and atrophy signaling pathways. , 2005, The international journal of biochemistry & cell biology.

[20]  In-Hyun Park,et al.  Mammalian Target of Rapamycin (mTOR) Signaling Is Required for a Late-stage Fusion Process during Skeletal Myotube Maturation*[boxs] , 2005, Journal of Biological Chemistry.

[21]  R. Loewith,et al.  Molecular Organization of Target of Rapamycin Complex 2* , 2005, Journal of Biological Chemistry.

[22]  J. Hershey,et al.  Changes in Ribosomal Binding Activity of eIF3 Correlate with Increased Translation Rates during Activation of T Lymphocytes* , 2005, Journal of Biological Chemistry.

[23]  Alexander R Ivanov,et al.  PCI proteins eIF3e and eIF3m define distinct translation initiation factor 3 complexes , 2005, BMC Biology.

[24]  Anne Poupon,et al.  Prediction of unfolded segments in a protein sequence based on amino acid composition , 2005, Bioinform..

[25]  N. Sonenberg,et al.  Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control , 2005, Nature Cell Biology.

[26]  Hongyi Zhou,et al.  Fold recognition by combining sequence profiles derived from evolution and from depth‐dependent structural alignment of fragments , 2004, Proteins.

[27]  R. Loewith,et al.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.

[28]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[29]  D. Guertin,et al.  Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.

[30]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[31]  J. Blenis,et al.  PI3-kinase and TOR: PIKTORing cell growth. , 2004, Seminars in cell & developmental biology.

[32]  Stefano Fumagalli,et al.  S6K1−/−/S6K2−/− Mice Exhibit Perinatal Lethality and Rapamycin-Sensitive 5′-Terminal Oligopyrimidine mRNA Translation and Reveal a Mitogen-Activated Protein Kinase-Dependent S6 Kinase Pathway , 2004, Molecular and Cellular Biology.

[33]  A. Goldberg,et al.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  J. Avruch,et al.  The Mammalian Target of Rapamycin (mTOR) Partner, Raptor, Binds the mTOR Substrates p70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) Motif* , 2003, The Journal of Biological Chemistry.

[35]  Maria Deak,et al.  A phosphoserine/threonine‐binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation , 2002, The EMBO journal.

[36]  J. Avruch,et al.  Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.

[37]  D. Sabatini,et al.  mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.

[38]  E. Calabria,et al.  A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Blenis,et al.  Identification of a Conserved Motif Required for mTOR Signaling , 2002, Current Biology.

[40]  A. Goldberg,et al.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Yancopoulos,et al.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.

[42]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[43]  Jie Chen,et al.  The Mammalian Target of Rapamycin Regulates C2C12 Myogenesis via a Kinase-independent Mechanism* , 2001, The Journal of Biological Chemistry.

[44]  A. Gingras,et al.  Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.

[45]  Tobias Schmelzle,et al.  TOR, a Central Controller of Cell Growth , 2000, Cell.

[46]  M. Leibovitch,et al.  Stabilization of MyoD by Direct Binding to p57Kip2 * , 2000, The Journal of Biological Chemistry.

[47]  P Bucher,et al.  The PCI domain: a common theme in three multiprotein complexes. , 1998, Trends in biochemical sciences.

[48]  N. Sonenberg,et al.  Translational control of gene expression , 2000 .

[49]  D. Eisenberg,et al.  Assessment of protein models with three-dimensional profiles , 1992, Nature.

[50]  D. Goldspink,et al.  Protein turnover measured in vivo and in vitro in muscles undergoing compensatory growth and subsequent denervation atrophy. , 1983, The Biochemical journal.

[51]  T. S. P. S.,et al.  GROWTH , 1924, Nature.

[52]  Narayanan Eswar,et al.  Protein structure modeling with MODELLER. , 2008, Methods in molecular biology.

[53]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[54]  J. Avruch,et al.  The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. , 2001, Progress in molecular and subcellular biology.

[55]  Gapped BLAST and PSI-BLAST: A new , 1997 .